PRO 190
Alternative Names: PRO-190Latest Information Update: 06 May 2024
At a glance
- Originator Laboratorios Sophia
- Class Eye disorder therapies; Polyethylene glycols; Propylene glycols
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Dry eyes
Most Recent Events
- 23 Apr 2024 Preclinical trials in Dry eyes in Mexico (Ophthalmic)
- 23 Apr 2024 Laboratorios Sophia plans a phase I trial for Dry eyes (In volunteers) (Ophthalmic) in September 2024 (NCT06379685)